Eating patterns of massively obese individuals.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to W T Dahms.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In a randomized double-blind trial, 60 obese patients were assigned in groups of 12 to five therapists. The patients for each therapist were then randomly assigned in groups of four to placebo or one of two preparations of mazindol. Ninety-three percent of the patients completed the nine weeks of treatment. Weight loss averaged 1.1 lb per week and there was no advantage to pharmacological agents over placebo. However, there were significant differences between therapists. Weight loss by the patients assigned to physicians was no better than for those assigned to nonphysician personnel, but there were significant differences between individual nonphysician personnel. These findings support the concept that nonphysician personnel may be effective in treating many obese patients. In addition, we could not find a significant effect of either form of mazindol when compared to placebo.
Patients attending weight reduction clinics were tested at the beginning of the program to assess a variety of background variables which might influence successful weight loss. These included measures of self-esteem, social acceptance, locus of control, responsiveness to external stimuli, attitudes toward weight loss, and knowledge about nutrition. Success was related to social conformity and desire for social acceptance but not to self esteem or locus of control. Individuals who believed that poor eating habits caused their obesity and those who were less responsive to environmental cues which may trigger feeding, were also more successful.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Type I diabetes mellitus, also called insulin-dependent diabetes mellitus or IDDM, is a significant chronic condition with implications for dental treatment. Advances in management include intensified therapy, highly purified insulins, and insulin pumps. Periodontal tissues are affected by IDDM, with resultant increases in disease in children affected with IDDM.